What is heart disease?
Heart disease — also called cardiovascular disease — is an umbrella term covering a range of conditions that affect the structure and function of the heart. The heart is a remarkable organ: roughly the size of your fist, it beats about 100,000 times a day, pumping five liters of blood per minute through a network of vessels that, laid end-to-end, would circle the Earth more than twice.
When disease disrupts any part of this intricate system — whether the muscle itself, the electrical signaling that coordinates each beat, the valves that regulate blood flow, or the arteries that supply the heart with oxygen — the consequences can be life-threatening.
The most common form is coronary artery disease (CAD), in which the arteries feeding the heart muscle become narrowed by plaque (atherosclerosis). Think of it like a slow-building blockage in a pipe: years or decades of plaque accumulation gradually restrict blood flow, and eventually a clot can completely block an artery — causing a heart attack.
"Heart disease," "cardiovascular disease," and "coronary heart disease" are used interchangeably in the media. Technically, cardiovascular disease is the broadest term (covering heart and blood vessel disease), while heart disease usually refers to conditions directly affecting the heart. This guide uses both terms to reflect standard clinical usage.
Types of heart disease
Heart disease is not a single condition — it is a family of related disorders, each with distinct mechanisms, symptoms, and treatments.
Coronary artery disease (CAD)
The most prevalent form, affecting approximately 18 million American adults. CAD develops when atherosclerotic plaque — a mixture of cholesterol, fat, calcium, and inflammatory cells — builds up inside the coronary arteries. This narrows the arterial lumen and reduces blood flow to the heart muscle. When plaque ruptures, a blood clot forms rapidly, potentially causing a heart attack (myocardial infarction).
Most people with CAD have no symptoms until the arteries are significantly narrowed — which is why regular cardiovascular risk assessment is so important. The first manifestation of CAD in some patients, tragically, is sudden cardiac death.
Heart failure
Heart failure does not mean the heart has stopped — it means the heart cannot pump enough blood to meet the body's needs. It affects about 6.7 million Americans and is the leading cause of hospitalization in people over 65. There are two main types:
- HFrEF (reduced ejection fraction): The heart muscle is weakened and cannot squeeze forcefully enough. Often caused by a prior heart attack.
- HFpEF (preserved ejection fraction): The heart squeezes normally but the muscle is stiff and cannot fill properly. More common in women, older adults, and those with hypertension or diabetes.
Arrhythmias
The heart's rhythm is controlled by an electrical system. When this system misfires, the result is an arrhythmia — an abnormal heart rhythm. These range from harmless palpitations to life-threatening ventricular fibrillation.
- Atrial fibrillation (AFib): The most common serious arrhythmia, affecting 6 million Americans. The upper chambers quiver chaotically, which can allow blood clots to form and dramatically increases stroke risk.
- Ventricular fibrillation: The most dangerous arrhythmia, causing sudden cardiac arrest. Requires immediate defibrillation.
- Bradycardia: Abnormally slow heart rate, sometimes requiring a pacemaker.
- SVT / tachycardia: Abnormally fast heart rate — ranges from benign to life-threatening depending on origin.
Valvular heart disease
The heart has four valves that keep blood flowing in the right direction. Valvular disease occurs when one or more valves don't open or close properly — either narrowing (stenosis) or leaking (regurgitation). The aortic and mitral valves are most commonly affected. Severe cases often require surgical or catheter-based repair or replacement.
Congenital heart disease
Structural heart defects present from birth, ranging from small holes between chambers (septal defects) to complex malformations. About 1 in 100 babies is born with some form of congenital heart defect. Thanks to advances in pediatric cardiac surgery, most children today survive to adulthood.
Cardiomyopathy
Disease of the heart muscle itself. Types include dilated (enlarged, weakened heart), hypertrophic (abnormally thickened muscle — a leading cause of sudden cardiac death in young athletes), and restrictive (stiffened heart muscle, often from infiltrative diseases like amyloidosis).
Symptoms and warning signs
Heart disease is insidious precisely because it often develops silently over decades. By the time symptoms appear, significant damage may already have occurred. Recognizing the warning signs — and knowing which ones demand emergency care — can be life-saving.
Chest pain, pressure, squeezing, or tightness · Pain spreading to jaw, left arm, back, or stomach · Sudden severe shortness of breath · Fainting or near-fainting · Sudden cold sweat · Sudden confusion or face drooping (possible stroke)
Cardiac symptom overview
| Symptom | Classic presentation | Atypical (often in women) | Urgency |
|---|---|---|---|
| Chest discomfort | Pressure, squeezing — "elephant on chest" | Burning, aching, or vague discomfort | Emergency |
| Radiating pain | Left arm, shoulder, neck | Jaw, back, both arms, upper abdomen | Emergency |
| Shortness of breath | With exertion or at rest | May be the only symptom | Emergency |
| Nausea / vomiting | Less common in men | More common, may dominate | Urgent |
| Cold sweat | Sudden diaphoresis | Similar | Emergency |
| Fatigue | Unusual, often preceding event | Can appear days or weeks before MI | See doctor |
| Angina | Chest pain with exertion, relieved by rest | May be less typical | Urgent |
Women are significantly more likely to present with atypical symptoms — nausea, jaw pain, extreme fatigue — rather than classic chest pressure. This leads to underdiagnosis and delayed treatment. Never dismiss cardiac symptoms in women simply because they don't fit the "classic" description.
Symptoms of heart failure
- Shortness of breath — especially lying flat (orthopnea) or waking at night (paroxysmal nocturnal dyspnea)
- Leg and ankle swelling (edema) — fluid accumulation
- Persistent cough or wheeze — fluid in the lungs
- Rapid weight gain — 2–3 lbs in a day from fluid retention
- Reduced exercise capacity — fatigue with minimal activity
- Confusion or difficulty concentrating — reduced brain perfusion
Causes and risk factors
Heart disease results from the interplay of genetic predisposition and environmental factors accumulated over a lifetime. Understanding your personal risk profile is the foundation of prevention.
Modifiable risk factors
🩺 Hypertension
- Affects 1 in 3 adults
- Damages arterial walls over time
- Silent — often no symptoms
- Target: below 130/80 mmHg
🩸 High Cholesterol
- LDL drives plaque formation
- Statins reduce risk 25–35%
- PCSK9 inhibitors for high-risk cases
- Diet and exercise also effective
🚬 Smoking
- Doubles heart disease risk
- Damages endothelium directly
- Risk drops rapidly after quitting
- 10 years post-quit: near normal
⚖️ Obesity / Diabetes
- Metabolic syndrome cluster
- Insulin resistance worsens risk
- GLP-1 drugs show CV benefit
- 5–10% weight loss is protective
🛋️ Physical Inactivity
- 150 min/week moderate exercise
- Reduces cardiac risk by 35%
- Improves all other risk factors
- Any amount helps
😰 Chronic Stress
- Elevates cortisol chronically
- Promotes vascular inflammation
- Often drives unhealthy behaviors
- Mindfulness shows modest benefit
Non-modifiable risk factors
- Age: Risk rises sharply after 45 in men, 55 in women
- Sex: Men have higher risk earlier; women's risk equalizes post-menopause
- Family history: First-degree relative with MI before 55 (men) or 65 (women) roughly doubles your risk
- Race: African Americans have higher rates of hypertension and cardiovascular mortality
- Genetic conditions: Familial hypercholesterolemia affects 1 in 250 people and can cause MI in young adults
Emerging risk factors
- Chronic inflammation — elevated hsCRP independently predicts cardiac events
- Sleep apnea — untreated OSA significantly elevates cardiovascular risk
- Autoimmune diseases — rheumatoid arthritis and lupus carry elevated cardiac risk
- Air pollution — particulate matter exposure is a significant population-level risk factor
- Lipoprotein(a) — a genetically determined independent risk factor, increasingly tested
How heart disease is diagnosed
Blood tests
| Test | What it measures | Clinical use |
|---|---|---|
| Lipid panel | Total cholesterol, LDL, HDL, triglycerides | Risk assessment, statin decisions |
| Troponin (I or T) | Heart muscle protein released during damage | Diagnosing heart attack — highly sensitive |
| BNP / NT-proBNP | Cardiac stress hormone | Diagnosing and monitoring heart failure |
| HbA1c | Blood sugar control | Identify diabetes as a risk factor |
| hsCRP | High-sensitivity C-reactive protein | Inflammation marker; refines risk in intermediate-risk patients |
| Lipoprotein(a) | Genetically determined lipid particle | Independent risk factor, increasingly screened |
Non-invasive imaging and testing
- Electrocardiogram (ECG): 12-lead recording of electrical activity. Essential first test — takes 5 minutes. Detects arrhythmias and signs of heart attack.
- Echocardiogram: Ultrasound of the heart. Shows heart size, muscle function (ejection fraction), valve function, and wall motion abnormalities. The single most informative non-invasive test.
- Stress testing: ECG during exercise or pharmacological stress. Unmasks CAD not apparent at rest. Can be combined with echo or nuclear imaging.
- CT coronary calcium score (CAC): Quantifies calcified plaque. Excellent for risk stratification — a score of zero is very reassuring.
- CT coronary angiography (CTCA): Detailed imaging of coronary arteries with contrast. Non-invasive alternative to catheterization.
- Cardiac MRI: Gold standard for heart muscle scarring, cardiomyopathy, and myocarditis. No radiation.
- Holter monitor: Portable ECG worn 24–48 hours to capture intermittent arrhythmias.
Invasive procedures
- Coronary angiography (cardiac cath): Gold standard for CAD severity — catheters deliver contrast dye to visualize blockages under X-ray. Often performed with immediate stenting if a significant blockage is found.
- Electrophysiology (EP) study: Maps the heart's electrical system to diagnose complex arrhythmias and guide ablation.
Treatment options
| Drug class | Examples | Primary use | Key benefit |
|---|---|---|---|
| Statins | Atorvastatin, Rosuvastatin | High cholesterol, CAD prevention | Reduce LDL 40–60%, stabilize plaque |
| PCSK9 inhibitors | Evolocumab, Alirocumab | Very high CV risk, statin intolerance | Reduce LDL up to 70% on top of statin |
| ACE inhibitors / ARBs | Lisinopril, Losartan | Heart failure, hypertension, post-MI | Reduce mortality in HFrEF by 20–25% |
| Beta-blockers | Carvedilol, Metoprolol | Heart failure, angina, post-MI | Reduce sudden cardiac death |
| SGLT2 inhibitors | Empagliflozin, Dapagliflozin | Heart failure, diabetes | Reduce HF hospitalization ~30% |
| Antiplatelet agents | Aspirin, Clopidogrel | Post-MI, post-stent | Prevent clot formation |
| Anticoagulants | Apixaban, Rivaroxaban | AFib (stroke prevention) | Reduce AFib stroke risk by 60–70% |
| Diuretics | Furosemide, Spironolactone | Heart failure fluid relief | Relieve congestion, improve symptoms |
| Nitrates | Nitroglycerin | Angina relief | Dilate coronary arteries rapidly |
Lifestyle medicine is the foundation of heart disease prevention — and more powerful than most people realize. The INTERHEART study found that nine modifiable risk factors account for over 90% of the risk for a first heart attack.
- Diet: The Mediterranean and DASH diets have the strongest evidence. Key elements: olive oil, fish, whole grains, legumes, nuts, and abundant vegetables. Limit red meat, refined carbohydrates, and ultra-processed foods.
- Physical activity: 150 minutes per week of moderate aerobic exercise reduces cardiac risk by 35%. Two sessions of resistance training per week provide additional metabolic benefits.
- Smoking cessation: The single most cost-effective intervention. Within one year of quitting, heart disease risk drops by 50%.
- Weight management: Every 1 kg of weight loss reduces systolic blood pressure by ~1 mmHg.
- Sleep: Target 7–9 hours. Both <6 and >9 hours are associated with increased cardiovascular risk.
- Alcohol: Previous guidance suggesting moderate alcohol was protective has been revised — current evidence suggests minimizing or avoiding alcohol.
- Pacemaker: Implanted device with leads to the heart. Delivers electrical impulses when heart beats too slowly. Essential for sick sinus syndrome and heart block.
- ICD (Implantable Cardioverter-Defibrillator): Like a pacemaker but delivers a life-saving shock for ventricular fibrillation. Recommended for EF <35% or prior cardiac arrest.
- CRT (Cardiac Resynchronization Therapy): Biventricular pacemaker coordinating both ventricles. Improves symptoms and survival in HFrEF with LBBB.
- LVAD (Left Ventricular Assist Device): Mechanical pump to support a failing heart — as a bridge to transplant or as permanent therapy.
Cardiac rehabilitation is a supervised, medically-directed program of exercise, education, and psychosocial support — one of the most underutilized yet evidence-backed interventions in cardiology.
- Typically 36 supervised exercise sessions over 12 weeks
- Reduces mortality after heart attack by up to 26%
- Reduces hospital readmission by 31%
- Includes education on heart-healthy eating, medications, and stress management
- Indicated after: MI, stenting, bypass surgery, heart failure, valve repair/replacement
- Sadly, only ~20–25% of eligible patients complete a program
Surgical and interventional procedures
PCI (Angioplasty and Stenting)
The most common cardiac procedure — over 600,000 performed annually in the U.S. A balloon catheter is threaded to the blocked artery (usually via the wrist) and inflated to compress the plaque, then a drug-eluting stent is deployed to keep the artery open. Most patients go home the next day. Dual antiplatelet therapy is required for 6–12 months after stenting.
Coronary Artery Bypass Grafting (CABG)
Open-heart surgery in which vessels harvested from the chest or leg are grafted around blocked coronary arteries. Preferred over PCI in patients with complex multi-vessel disease, diabetes, or left main stenosis — offering better long-term outcomes in these scenarios. Higher upfront risk but superior durability.
Valve procedures
- Surgical valve repair or replacement: Traditional open-heart approach. Mechanical valves last longer but require lifelong anticoagulation; biological valves don't but may wear out in 15–20 years.
- TAVR: Revolutionary catheter-based replacement for aortic stenosis — delivered via femoral artery without open-heart surgery. Most patients leave hospital within 2–3 days.
- MitraClip: Catheter-based clip to repair leaking mitral valves in high-surgical-risk patients.
Ablation for arrhythmias
Catheters deliver radiofrequency energy or cryoablation to destroy tissue causing abnormal electrical pathways. Highly effective for atrial flutter (90%+ cure) and increasingly for AFib (65–80% success for paroxysmal AFib).
Prevention: Life's Essential 8
The AHA's "Life's Essential 8" identifies the key metrics for optimal cardiovascular health:
- Blood pressure: Below 120/80 mmHg. Check annually if normal.
- Blood glucose: Fasting below 100 mg/dL, HbA1c below 5.7%.
- Cholesterol: LDL below 100 mg/dL (below 70 with established heart disease).
- Healthy weight: BMI 18.5–24.9; monitor waist circumference too.
- Physical activity: 150+ min/week moderate or 75+ min vigorous aerobic exercise.
- Healthy diet: Emphasize vegetables, fruits, whole grains, legumes, fish, and nuts.
- Avoid tobacco: Never smoke; quit immediately if you do.
- Sleep: 7–9 hours nightly. Screen for sleep apnea if you snore heavily.
Aspirin for primary prevention is now recommended only for people aged 40–59 with ≥10% 10-year cardiovascular risk and no bleeding risk. It is generally not recommended for those 60+ initiating it for the first time. The bleeding risk outweighs the benefit in most people. Talk to your doctor before starting or stopping aspirin.
Living with heart disease
A diagnosis of heart disease can be frightening — but it is not the end. Millions of people live full, active lives with heart disease when it is properly managed.
Medication adherence
Cardiovascular medications only work when taken consistently. Stopping statins, beta-blockers, or antiplatelet therapy abruptly can trigger a "rebound" effect and significantly increases cardiac risk. If cost, side effects, or regimen complexity is making adherence difficult, talk to your cardiologist — there are almost always solutions.
Monitoring
Regular follow-up allows your care team to adjust treatment as your condition evolves. Invest in a validated home blood pressure monitor — it gives your doctor far more data than a single office reading.
Emotional wellbeing
Depression and anxiety are two to three times more common in people with heart disease — and they independently worsen cardiovascular outcomes. If you're struggling emotionally after a cardiac event, ask for a referral to cardiac psychology or a mental health professional. This is not a secondary concern — it's part of comprehensive cardiac care.
Sexual activity and travel
Most people with well-controlled heart disease can resume sexual activity — the cardiac demand is roughly equivalent to climbing two flights of stairs. Air travel is also safe for most patients; discuss with your cardiologist if you've had a recent event or have decompensated heart failure.
Frequently asked questions
Coronary artery disease (CAD) is the most common type, affecting approximately 18 million American adults. It is caused by atherosclerosis — the buildup of fatty plaque inside the coronary arteries. CAD is responsible for most heart attacks and the majority of heart disease deaths worldwide.
Research by Dr. Dean Ornish demonstrated that significant lifestyle changes — a very low-fat diet, regular aerobic exercise, stress management, and smoking cessation — can partially reverse coronary artery disease. Aggressive statin and PCSK9-inhibitor therapy can also stabilize and modestly regress atherosclerotic plaque. Complete reversal is generally not achievable, but meaningful arrest of progression is a proven clinical goal.
Early warning signs include chest discomfort with exertion (angina), unexplained shortness of breath, palpitations, and unusual fatigue — especially in women, who may experience these symptoms days or weeks before a cardiac event. Crucially, many people with significant CAD have no symptoms until a heart attack or sudden cardiac death occurs, which is why proactive risk assessment matters enormously after age 40.
CT coronary calcium scoring (CAC) can identify calcified plaque without physical exertion — it takes about 10 minutes with minimal radiation. CT coronary angiography (CTCA) provides even more detail. Pharmacological stress testing with adenosine, regadenoson, or dobutamine is another option for those unable to exercise adequately.
Atherosclerosis begins far earlier than most people realize — fatty streaks have been found in children as young as 3 years old. By the teenage years, early plaque lesions can be present in those with significant risk factors. Clinically significant disease typically manifests from age 45 in men and 55 in women, though familial hypercholesterolemia can cause heart attacks in people in their 20s and 30s.
Yes, genetics play a significant role. A first-degree relative who had a heart attack before age 55 (men) or 65 (women) roughly doubles your personal risk. Familial hypercholesterolemia (FH) — affecting 1 in 250 people — causes severely elevated LDL from birth and dramatically increases risk even independent of diet or lifestyle. If you have a strong family history, discuss it with your doctor — you may benefit from earlier screening and preventive treatment.
- Virani SS, et al. Heart Disease and Stroke Statistics—2023 Update. Circulation. 2023;147(8):e93–e621.
- Roth GA, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019. J Am Coll Cardiol. 2020;76(25):2982–3021.
- Yusuf S, et al. Effect of potentially modifiable risk factors (INTERHEART study). Lancet. 2004;364(9438):937–952.
- Heidenreich PA, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. JACC. 2022;79(17):e263–e421.
- Grundy SM, et al. 2018 AHA/ACC Guideline on the Management of Blood Cholesterol. JACC. 2019;73(24):e285–e350.
- Ornish D, et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA. 1998;280(23):2001–2007.
- Lloyd-Jones DM, et al. Life's Essential 8: Updating and Enhancing the American Heart Association's Construct of Cardiovascular Health. Circulation. 2022;146(5):e18–e43.